Pavel Videv

Dr. Pavel Videv

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
AKAlexandra Kapogianni
Alexandra Kapogianni
GRGabriela Radulova
Gabriela Radulova
VDVancho Donev
Vancho Donev
PVPavel Videv
Pavel Videv
GCGinka Cholakova
Ginka Cholakova
ITIvanka Tsacheva
Ivanka Tsacheva
C1q, the key component of the classical pathway of the Complement system, is known for its vast functional activity including clearance of apoptotic cells. The binding of C1q to apoptotic blebs occurs via an interaction with the phosphatidylserine externalized on the cell surface. In this study, we characterized the interaction between C1q and phosphatidylserine, with emphasis on the structure of the phosphatidylserine-binding site within the globular domains of C1q and the nature of binding of C1q with phosphatidylserine, using both in vitro and in silico methods. We established that all three globular fragments, forming one C1q globular domain, bound phosphatidylserine with the leading role of the phosphatidylserine-binding site pertaining to the A chain of the globular fragment of C1q. We also determined the closest-contact amino acids of C1q participating in the interaction with phosphatidylserine. An important role is suggested for the glycosylated Asn124 residue in the A chain of the globular fragment.

2 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
PVPavel Videv
Pavel Videv
KMKirilka Mladenova
Kirilka Mladenova
TATonya Andreeva
Tonya Andreeva
JPJong Hun Park
Jong Hun Park
VDVeselina Moskova- Doumanova
Veselina Moskova- Doumanova
JDJordan Doumanov
Jordan Doumanov
Human retinal pigment epithelial (RPE) cells express the transmembrane Ca2+-dependent Cl− channel bestrophin-1 (hBest1) of the plasma membrane. Mutations in the hBest1 protein are associated with the development of distinct pathological conditions known as bestrophinopathies. The interactions between hBest1 and plasma membrane lipids (cholesterol (Chol), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and sphingomyelin (SM)) determine its lateral organization and surface dynamics, i.e., their miscibility or phase separation. Using the surface pressure/mean molecular area (π/A) isotherms, hysteresis and compressibility moduli (Cs−1) of hBest1/POPC/Chol and hBest1/SM/Chol composite Langmuir monolayers, we established that the films are in an LE (liquid-expanded) or LE-LC (liquid-condensed) state, the components are well-mixed and the Ca2+ ions have a condensing effect on the surface molecular organization. Cholesterol causes a decrease in the elasticity of both films and a decrease in the ΔGmixπ values (reduction of phase separation) of hBest1/POPC/Chol films. For the hBest1/SM/Chol monolayers, the negative values of ΔGmixπ are retained and equalized with the values of ΔGmixπ in the hBest1/POPC/Chol films. Shifts in phase separation/miscibility by cholesterol can lead to changes in the structure and localization of hBest1 in the lipid rafts and its channel functions.

12 July 2025 in Molecules
Verified
Journal Article
Open access
PDF file
PBPavel Bakardzhiev
Pavel Bakardzhiev
TKTeodora Petrova Koleva
Teodora Petrova Koleva
KMKirilka Mladenova
Kirilka Mladenova
PVPavel Videv
Pavel Videv
VDVeselina Moskova- Doumanova
Veselina Moskova- Doumanova
JDJordan Doumanov
Jordan Doumanov
Bestrophinopathies are a group of inherited retinal diseases caused by mutations in the BEST1 gene. The protein encoded by this gene, bestorphin-1 (hBest1), is a calcium-dependent transmembrane channel localized on the basolateral membrane of retinal pigment epithelial (RPE) cells. We have already demonstrated the surface behavior and organization of recombinant hBest1 and its interactions with membrane lipids such as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), sphingomyelin (SM) and cholesterol (Chol) in models of biological membranes, which affect the hBest1 structure–function relationship. The main aim of our current investigation is to integrate pure hBest1 protein into lipid bilayer nanostructures. We synthesized and characterized various hBest1-containing nanostructures based on 1,2-Dipalmitoylphosphatidylcholine (DPPC), SM, glycerol monooleate (GMO) and Chol in different ratios and determined their cytotoxicity and incorporation into cell membranes and/or cells by immunofluorescence staining. Our results show that these newly designed nanoparticles are not cytotoxic and that their incorporation into MDCK II cell membranes (used as a model system) may provide a mechanism that could be applied to RPE cells expressing mutated hBest1 in order to restore their ion transport functions, affected by mutated and malfunctioning hBest1 molecules.